Balraj Singh Bajwa, NP
Nurse Practitioner · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Momentum for Health · 41 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Balraj Singh Bajwa’s office at (408) 938-6750 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$1,847
Medicare paid this office $1,847 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 47 · 85 and older 0% · Also on Medicaid 100% · Health risk score 1.00. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
The office billed $9,389, Medicare allowed $2,927 and paid $1,847; for 27 services of 4 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 13 | 27 | 47 | 1.00 | $9,389 | $1,847 |
| 2022 | 16 | 45 | 43 | 0.77 | $8,929 | $4,394 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$233,437
Pharmacies billed $233,437 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 969) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
898 generic and 71 brand-name prescriptions · $233,437 in drug cost · 81 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Invega Sustenna | 38 | $100,945 | $2,656 |
| Clozapine | 101 | $9,065 | $90 |
| Clozapine Odt | 11 | $2,420 | $220 |
| Divalproex Sodium Er | 21 | $1,918 | $91 |
| Atomoxetine | 19 | $1,739 | $92 |
See all 27 drugs
| Invega Sustenna | 38 | $100,945 | $2,656 |
| Clozapine | 101 | $9,065 | $90 |
| Clozapine Odt | 11 | $2,420 | $220 |
| Divalproex Sodium Er | 21 | $1,918 | $91 |
| Atomoxetine | 19 | $1,739 | $92 |
| Olanzapine | 87 | $1,704 | $20 |
| Guanfacine | 12 | $1,037 | $86 |
| Aripiprazole | 37 | $888 | $24 |
| Divalproex | 18 | $623 | $35 |
| Haloperidol | 17 | $570 | $34 |
| Hydroxyzine | 54 | $516 | $10 |
| Quetiapine | 38 | $491 | $13 |
| Risperidone | 61 | $469 | $8 |
| Benztropine Mesylate | 34 | $366 | $11 |
| Propranolol | 15 | $344 | $23 |
| Trihexyphenidyl | 17 | $298 | $18 |
| Clonazepam | 32 | $184 | $6 |
| Bupropion Xl | 12 | $156 | $13 |
| Lorazepam | 35 | $133 | $4 |
| Trazodone | 23 | $133 | $6 |
| Mirtazapine | 16 | $130 | $8 |
| Sertraline | 21 | $111 | $5 |
| Buspirone | 14 | $105 | $8 |
| Escitalopram | 26 | $90 | $3 |
| Fluoxetine | 19 | $74 | $4 |
| Zolpidem | 11 | $46 | $4 |
| Citalopram Hbr | 11 | $27 | $2 |
Year by year
| 2024 | 969 | 180 | 0% (0) | 7% | $233,437 |
| 2023 | 1,261 | 221 | 0% (0) | None | $399,326 |
| 2022 | 720 | 164 | 0% (0) | None | $188,890 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Invega Sustenna | 66 | $195,210 | $2,958 |
| Aripiprazole | 48 | $10,746 | $224 |
| Clozapine | 88 | $9,511 | $108 |
| Olanzapine | 72 | $4,461 | $62 |
| Quetiapine | 103 | $3,490 | $34 |
| Risperidone | 90 | $2,265 | $25 |
| Benztropine Mesylate | 58 | $1,186 | $20 |
| Divalproex | 23 | $1,143 | $50 |
| Haloperidol | 22 | $1,046 | $48 |
| Divalproex Sodium Er | 18 | $809 | $45 |
| Haloperidol Decanoate | 13 | $783 | $60 |
| Hydroxyzine | 28 | $733 | $26 |
| Lorazepam | 37 | $515 | $14 |
| Bupropion Xl | 22 | $491 | $22 |
| Clonazepam | 42 | $467 | $11 |
| Sertraline | 35 | $444 | $13 |
| Fluoxetine | 33 | $439 | $13 |
| Oxcarbazepine | 15 | $417 | $28 |
| Buspirone | 44 | $364 | $8 |
| Gabapentin | 34 | $352 | $10 |
| Paroxetine | 26 | $320 | $12 |
| Mirtazapine | 27 | $252 | $9 |
| Propranolol | 23 | $250 | $11 |
| Trazodone | 26 | $235 | $9 |
| Escitalopram | 11 | $184 | $17 |
| Zolpidem | 25 | $144 | $6 |
| Lithium Carbonate | 18 | $117 | $6 |
| Lamotrigine | 12 | $93 | $8 |
| Duloxetine | 11 | $79 | $7 |
2022: 20 drugs
| Invega Sustenna | 21 | $60,418 | $2,877 |
| Clozapine | 72 | $7,669 | $107 |
| Aripiprazole | 17 | $4,285 | $252 |
| Quetiapine | 43 | $1,529 | $36 |
| Divalproex | 16 | $1,010 | $63 |
| Haloperidol Decanoate | 17 | $992 | $58 |
| Haloperidol | 11 | $840 | $76 |
| Risperidone | 61 | $800 | $13 |
| Olanzapine | 32 | $641 | $20 |
| Bupropion Xl | 13 | $502 | $39 |
| Benztropine Mesylate | 21 | $340 | $16 |
| Hydroxyzine | 11 | $329 | $30 |
| Clonazepam | 16 | $264 | $17 |
| Trazodone | 30 | $237 | $8 |
| Gabapentin | 52 | $215 | $4 |
| Buspirone | 36 | $180 | $5 |
| Lorazepam | 22 | $169 | $8 |
| Fluoxetine | 15 | $145 | $10 |
| Sertraline | 17 | $127 | $7 |
| Paroxetine | 13 | $106 | $8 |
Money from drug and device companies
$625 in 2023
| 2023 | 4 | 7 | None | $625 |
| 2022 | 2 | 2 | None | $153 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alkermes | Lybalvi | $311 | 3 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $200 | 2 payments
|
| Teva Pharmaceuticals USA | Uzedy | $90 | 1 payment
|
| Axsome Therapeutics | Auvelity | $23 | 1 payment
|
See all 7 published payments
| Teva Pharmaceuticals USA | Meals · 2023-08-23 | Uzedy | $90 |
| Janssen Pharmaceuticals | Education · 2023-07-28 | Invega Sustenna | $66 |
| Janssen Pharmaceuticals | Meals · 2023-05-15 | Invega Sustenna | $134 |
| Axsome Therapeutics | Meals · 2023-04-18 | Auvelity | $23 |
| Alkermes | Meals · 2023-03-08 | Vivitrol | $100 |
| Alkermes | Meals · 2023-01-31 | Aristada | $96 |
| Alkermes | Meals · 2023-01-25 | Lybalvi | $116 |
See earlier years (2022)
2022: $153
| Alkermes | Aristada | $120 | 1 payment
|
| Iti | Caplyta | $33 | 1 payment
|
Professional record
- NPI
- 1285191742
- Licence
- CA 95020092, CA 95172660
- Group
- Momentum for Health
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 2001 the Alameda, San Jose, CA, 95126
- NPI first listed
- 2019-02-20
- NPI last updated
- 2022-08-03
- NPI record certified
- 2022-08-03
This is when the NPI record was last certified, not a medical board exam.